IL109037A0 - Method and compositions for inducing phase separation of epithelial lipid bilayers - Google Patents

Method and compositions for inducing phase separation of epithelial lipid bilayers

Info

Publication number
IL109037A0
IL109037A0 IL10903794A IL10903794A IL109037A0 IL 109037 A0 IL109037 A0 IL 109037A0 IL 10903794 A IL10903794 A IL 10903794A IL 10903794 A IL10903794 A IL 10903794A IL 109037 A0 IL109037 A0 IL 109037A0
Authority
IL
Israel
Prior art keywords
compositions
phase separation
lipid bilayers
inducing phase
epithelial lipid
Prior art date
Application number
IL10903794A
Other versions
IL109037A (en
Original Assignee
Cellegy Pharma Inc
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellegy Pharma Inc, Univ California filed Critical Cellegy Pharma Inc
Publication of IL109037A0 publication Critical patent/IL109037A0/en
Publication of IL109037A publication Critical patent/IL109037A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
IL10903794A 1993-03-19 1994-03-18 Compositions for inducing phase separation of epithelial lipid bilayers and preparation of said compositions IL109037A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3380793A 1993-03-19 1993-03-19

Publications (2)

Publication Number Publication Date
IL109037A0 true IL109037A0 (en) 1994-06-24
IL109037A IL109037A (en) 1999-01-26

Family

ID=21872550

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10903794A IL109037A (en) 1993-03-19 1994-03-18 Compositions for inducing phase separation of epithelial lipid bilayers and preparation of said compositions

Country Status (3)

Country Link
AU (1) AU6589494A (en)
IL (1) IL109037A (en)
WO (1) WO1994021230A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6190894B1 (en) 1993-03-19 2001-02-20 The Regents Of The University Of California Method and compositions for disrupting the epithelial barrier function
IL110943A (en) * 1994-09-13 1997-02-18 Univ Ramot Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders
JPH10506531A (en) * 1994-09-19 1998-06-30 ザ ボード オブ トラスティーズ オブ ザ リランド スタンフォード ジュニア ユニバーシティー Malaria Disease Treatment
US5863716A (en) * 1994-09-19 1999-01-26 The Leland Stanford Junior University Board Of Trustees Treatment of plasmodium
JPH11292787A (en) * 1995-08-15 1999-10-26 Asahi Chem Ind Co Ltd Transucosal preparation containing physiologically active peptide
DE19541260A1 (en) * 1995-11-06 1997-05-07 Lohmann Therapie Syst Lts Therapeutic preparation for transdermal application of active ingredients through the skin
WO1998017253A1 (en) * 1996-10-23 1998-04-30 The Regents Of The University Of California Method and compositions for disrupting the epithelial barrier function
US20060002949A1 (en) 1996-11-14 2006-01-05 Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. Transcutaneous immunization without heterologous adjuvant
USRE37770E1 (en) 1997-01-24 2002-06-25 The Regents Of The University Of California Treatment of skin conditions by use of PPARα activators
US6060515A (en) * 1997-01-24 2000-05-09 The Regents Of The University Of California Treatment of skin conditions by use of PPARα activators
US6060043A (en) * 1998-02-03 2000-05-09 The Gillette Company Deodorant composition containing D-amino acid
WO2000066105A2 (en) * 1999-04-30 2000-11-09 The Trustees Of Boston College Treatment of epilepsy with imino sugars
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
NZ524646A (en) * 2000-09-08 2004-10-29 Alza Corp Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closure
DE10214506A1 (en) * 2002-04-02 2003-10-16 Beiersdorf Ag Use of deoxynojirimycin and its derivatives for the treatment and prophylaxis of degenerative skin conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177267A (en) * 1963-12-09 1979-12-04 Crown Zellerbach Enhancing tissue penetration of physiologically active steroidal agents with DMSC
US5073372A (en) * 1990-11-30 1991-12-17 Richardson-Vicks, Inc. Leave-on facial emulsion compositions
US5215759A (en) * 1991-10-01 1993-06-01 Chanel, Inc. Cosmetic composition

Also Published As

Publication number Publication date
AU6589494A (en) 1994-10-11
WO1994021230A1 (en) 1994-09-29
IL109037A (en) 1999-01-26

Similar Documents

Publication Publication Date Title
IL109037A0 (en) Method and compositions for inducing phase separation of epithelial lipid bilayers
AP2001002270A0 (en) Metalloproteinaise inhibitors pharmaceutical compositions containing them and their pharmaceeutical uses and methods and intermediates useful for their preparation
EP0863748A4 (en) Liposomal compositions and methods of using them
AU623004B2 (en) Solid imaging method utilizing photohardenable compositions of self limiting thickness by phase separation
EP0818989A4 (en) Novel compositions of lipids and stabilizing materials
EP0729997A3 (en) Method for preparation of block copolysiloxanecarbonates
AU4955496A (en) Method for determination of cholesterol in low-density lipoprotein or very low-density lipoprotein
EP0763741A4 (en) Method of quantitating cholesterol in low-density lipoprotein
AU4751296A (en) Method of suspending inclusions and compositions produced thereby
GB9219656D0 (en) Paper-like film and method and compositions for making it
EP0719854A3 (en) Process for the fractionation or refining of lipid natural substances
AU6413694A (en) Methods and compositions for inducing phase separation of epithelial lipid bilayers
AU1448092A (en) Splitter and method of forming it
HUT63782A (en) Method for continuous separation of particles
HUP0001534A3 (en) Phospholipid derivatives of phosphono-carboxylic acids and pharmaceutical compositions containing them
ZA968504B (en) Cleaning compositions containing lime-soap dispersnat and method of preparation
AU3584697A (en) Packing for separation columns and process of use
AU7014794A (en) Apparatus and method for separation of liquids
GB9507297D0 (en) New composition of matter
AU5531494A (en) Lipid containing formulation and method for its preparation
IL122651A (en) Zwitterionic polymorphic forms of trovafloxacin their preparation and pharmaceutical compositions containing them
SG69993A1 (en) Film method for forming protruded portions of plasma display using the same and plasma display fabricated by the method
AU1178692A (en) Method for separation of lactoserum proteins and products thus obtained
IL117017A0 (en) Locating wedge for separating mass of articles
GB9621751D0 (en) Method of separation

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed